| 51 |
Role of Oral Activated Charcoal in decreasing Blood Urea, Creatinine and Phosphorous in Chronic Kidney Disease |
2022 |
| 52 |
Serum Zinc Levels in Chronic Kidney Disease patients, Hemodialysis Patients, and Healthy Controls: Systematic Review and Meta-analysis |
2022 |
| 53 |
Significance of the mathematically calculated red cell indices in patients with qualitative and quantitative hemoglobinopathies |
2022 |
| 54 |
Some virulence genes of Staphylococcus aureus isolated from infected vascular accesses in hemodialysis patients at Assiut University Hospitals |
2022 |
| 55 |
The efficacy and safety of niacin on hyperphosphatemia in ESRD patients undergoing hemodialysis: Randomized controlled trial |
2022 |
| 56 |
Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study |
2021 |
| 57 |
Comparative study of intravenous high dose dexamethazone versus intravenous methylpredisolone as an emergent therapy in severe primary immune thrombocytopenia |
2021 |
| 58 |
Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin |
2021 |
| 59 |
Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin |
2021 |
| 60 |
Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin |
2021 |
هل لديك سؤال ؟
